Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
2021-10-22
A vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration NEW YORK, Oct 21 (Reuters) – The Pfizer (PFE.N)/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S.Continue Reading